@ECAware

A grass-roots not for profit organization on a mission to reduce the incidence and impact of Esophageal Cancer

 worldwide
ecaware.org
Joined May 2010
  • Tweets8.4K
  • Following1.3K
  • Followers1.1K
767Media
bioengineer.org/lymph-node-s…

Lymph Node Status After Chemoimmunotherapy Predicts Survival in Esophageal

A retrospective cohort study of 194 patients with esophageal squamous cell carcinoma found that postoperative pathological lymph node stage, rather than pre-treatment clinical node status, was the...

bioengineer.org
6
oncodaily.com/oncolibrary/ra…

Can Surgery Be Avoided After Chemoradiotherapy for Esophageal Cancer? Long-Term SANO Trial Results...

Can Surgery Be Avoided After Chemoradiotherapy for Esophageal Cancer? Long-Term SANO Trial Results / chemoradiotherapy, esmo 2026, ESMO 26, esophageal cancer,

oncodaily.com
12
medscape.com/viewarticle/act…
17
consumeraffairs.com/news/hot…

Hot drinks may come with a cancer risk few coffee drinkers consider

Drinking beverages at very hot temperatures was linked to a higher risk of one type of esophageal cancer.People drinking six or more hot drinks a day also

consumeraffairs.com
21
bioengineer.org/immunotherap…

Immunotherapy, AI and an Aging Population Are Rewriting Esophageal Cancer

Esophageal cancer has long been one of the most lethal and unforgiving of the major malignancies, but the ground beneath the surgeon’s feet is shifting faster now than at any point in the past two...

bioengineer.org
22
auntminnie.com/resources/con…

ASTRO: How does tumor location affect survival in patients with esophageal cancer?

Upper esophageal tumors were associated with the best survival, while middle esophageal location carried significantly worse odds.

auntminnie.com
35
koreabiomed.com/news/article…

Opdivo moves closer to Korea coverage in esophageal, liver cancers, setting up price battle - Korea...

Bristol Myers Squibb's immunotherapy Opdivo (nivolumab) has cleared a key hurdle toward expanded reimbursement in Korea for first-line treatment of esophageal squamous cell carcinoma and hepatocell...

koreabiomed.com
22
nature.com/articles/s41467-0…

First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanc...

Nature Communications - The RATIONALE-306 trial demonstrated improved overall survival in participants with advanced/metastatic esophageal squamous cell carcinoma treated with tislelizumab plus...

nature.com
30
health.yahoo.com/conditions/…

How much alcohol it takes to increase your risk of dying of 9 cancers: study

A bottle a day probably won’t keep the doctor at bay.

health.yahoo.com
1
22
oncodaily.com/oncolibrary/im…

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced...

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC / biomarker analysis, chemoimmunotherapy, clinical

oncodaily.com
32
nature.com/articles/s41388-0…

ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell...

Oncogene - ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression

nature.com
26
sciencedaily.com/releases/20…

Scientists find breast cancer cells hiding behind protective “shields”

Researchers have mapped breast tumors in striking detail and uncovered hidden pockets of dormant cancer cells that may help explain why cancer can return after treatment. Unlike rapidly dividing...

sciencedaily.com
28
targetedonc.com/view/growing…

Growing Alcohol-Attributable Cancer Burden in US Reveals Prevention Gap | Targeted Oncology -...

U.S. alcohol-linked cancer deaths double since 1990, led by surging liver cancer; men, older adults hit hardest, with wide state-by-state gaps.

targetedonc.com
24
facebook.com/share/r/1bZovRM…
28
aacrjournals.org/cancerres/a…

Single-Cell Analysis of Residual Esophageal Squamous Cell Carcinoma after Neoadjuvant Immunochemo...

TFAM mediates dendritic cell activation through the STING-TBK1-IRF3 pathway and is associated with responsiveness to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma, identifying...

aacrjournals.org
30
mainichi.jp/english/articles…

Viral therapy for esophageal cancer launched in Japan in world first

TOKYO -- A virus-based esophageal cancer drug developed by a startup from Okayama University has gone on sale following approval from Japan's health m

mainichi.jp
1
26
cureus.com/articles/364796-e…

Esophageal Perforation During Dilation in a Patient With Hypopharyngeal Metastatic Squamous Cell...

We report the case of a 75-year-old female with a history of stage IVa hypopharyngeal squamous cell carcinoma who presented with dysphagia due to cervical esophageal stricture after prior laryng...

cureus.com
26
aacrjournals.org/cancerres/a…

Phase Separation of ZBED2 Stabilizes ILK to Drive Metastasis and Immune Evasion in Esophageal...

AbstractMetastasis remains a leading cause of mortality in patients with esophageal squamous cell carcinoma (ESCC), underscoring the urgent need to elucidate the molecular mechanisms driving disease...

aacrjournals.org
33
spectrumnews1.com/oh/clevela…

Ohio man thankful for new treatment to overcome esophageal cancer

Dr. Robert Van Haren says Marmer was the first patient ever at the University of Cincinnati Health to receive chemo and immunotherapy both before and after surgery.

spectrumnews1.com
28
oncodaily.com/science/alexan…

Alexander Rühle: Multimodal Treatment Outcomes in Older Adults with Resectable Gastric Cancer -...

Alexander Rühle: Multimodal Treatment Outcomes in Older Adults with Resectable Gastric Cancer / Alexander Rühle, Alina Krause, Australasian Gastro-Intestinal

oncodaily.com
21
Load more